Andrew J. Gunderson, Ph.D.
Affiliations: | 2012 | Pennsylvania State University, State College, PA, United States |
Area:
Immunology, Cell Biology, OncologyGoogle:
"Andrew Gunderson"Parents
Sign in to add mentorAdam B. Glick | grad student | 2012 | Penn State | |
(The tumor promoting roles of lymphocytes during RAS initiated inflammation and skin carcinogenesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Khanal S, Wieland A, Gunderson AJ. (2023) Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity. Frontiers in Immunology. 14: 1267654 |
Medler TR, Kramer G, Bambina S, et al. (2023) Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help. Scientific Reports. 13: 6277 |
Zheng C, Fass JN, Shih YP, et al. (2022) Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. Cancer Cell. 40: 410-423.e7 |
Bernard B, Rajamanickam V, Dubay C, et al. (2020) Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer. Plos One. 15: e0238380 |
Gunderson AJ, Yamazaki T, McCarty K, et al. (2020) TGFβ suppresses CD8 T cell expression of CXCR3 and tumor trafficking. Nature Communications. 11: 1749 |
Gunderson AJ, Yamazaki T, McCarty K, et al. (2019) Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma. Plos One. 14: e0211117 |
Gunderson A, Yamazaki T, McCarty K, et al. (2019) TGFβR1 Antagonism Improves Radiation Efficacy By Relieving CXCR3 Suppression and Enhancing Tumor Recruitment of CD8+ T Cells International Journal of Radiation Oncology*Biology*Physics. 105: S87-S88 |
Elhalawani H, He R, Yamazaki T, et al. (2019) Multiparametric MRI Measures Correlate with Treatment Response and CD8 T Cell Infiltrate in Phase II Study of Tgfβri Inhibitor with Chemoradiation in Locally Advanced Rectal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: S58-S59 |
Podolsky MA, Bailey JT, Gunderson AJ, et al. (2017) Differentiated state of initiating tumor cells is key to distinctive immune responses seen in H-RasG12V-induced squamous tumors. Cancer Immunology Research |
Glick AB, Bailey JT, Gunderson A, et al. (2017) Abstract 2673: Divergent therapeutic responses to CD40L blockade or CD40 activation in Ras-driven skin cancers determined by origin of tumor initiating cell Cancer Research. 77: 2673-2673 |